The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Open accessAbstract
Because undesirable pharmacokinetics and toxicity are significant reasons for the failure of drug development in the costly late stage, it has been widely recognized that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. Concurrently, drug recalls have become increasingly common in recent years, prompting pharmaceutical companies to increase attention toward the safety evaluation of preclinical drugs. In vitro and in vivo drug evaluation techniques are currently more mature in preclinical applications, but these technologies are costly. In recent years, with the rapid development of computer science, in silico technology has been widely used to evaluate the relevant properties of drugs in the preclinical stage and has produced many software programs and in silico models, further promoting the study of ADMET in vitro. In this review, we first introduce the two ADMET prediction categories (molecular modeling and data modeling). Then, we perform a systematic classification and description of the databases and software commonly used for ADMET prediction. We focus on some widely studied ADMT properties as well as PBPK simulation, and we list some applications that are related to the prediction categories and web tools. Finally, we discuss challenges and limitations in the preclinical area and propose some suggestions and prospects for the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00104 · Cited by 5,716
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300367a · Cited by 2,222
Self-citationDrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993
Self-citationADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties
Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty707 · Cited by 1,423
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
The CompTox Chemistry Dashboard: a community data resource for environmental chemistry
Williams, A. J., Grulke, C. M., Edwards, J., McEachran, A. D., Mansouri, K., Baker, N. C., Patlewicz, G., Shah, I., Wambaugh, J. F., Judson, R. S., et al. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0247-6 · Cited by 1,143
The Comparative Toxicogenomics Database: update 2019
Davis, A. P., Grondin, C. J., Johnson, R. J., Sciaky, D., McMorran, R., Wiegers, J., Wiegers, T. C., & Mattingly, C. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky868 · Cited by 976
Dong, J., Wang, N.-N., Yao, Z.-J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0283-x · Cited by 889
ADMET modeling approaches in drug discovery
Ferreira, L. L. G., & Andricopulo, A. D. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.015 · Cited by 825
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762 · cited 1×
“In recent years, structure-based methods have been widely used, for instance, to predict the binding patterns of substrates ( Macalino et al., 2015), conformational changes in enzymes (Cheng T. et al., 2012), and their catalytic effects on physiological systems (Cui and Karplus, 2003), to evaluate…”
MethodPhysiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgment
Bhatia, S. P., Schultz, T. W., Roberts, D. W., Shen, J., Kromidas, L., & Api, A. M. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.11.005 · Cited by 605
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9322-0 · Cited by 574
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
An evaluation of the implementation of the Cramer classification scheme in the Toxtree software
Patlewicz, G., Jeliazkova, N., Safford, R. J., Worth, A. P., & Aleksiev, B. (2008) · SAR and QSAR in Environmental Research · doi:10.1080/10629360802083871 · Cited by 512
Neighborhood Behavior: A Useful Concept for Validation of “Molecular Diversity” Descriptors
Patterson, D. E., Cramer, R. D., Ferguson, A. M., Clark, R. D., & Weinberger, L. E. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960290n · Cited by 509
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
Comparative Studies on Some Metrics for External Validation of QSPR Models
Roy, K., Mitra, I., Kar, S., Ojha, P. K., Das, R. N., & Kabir, H. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200520g · Cited by 460
PBPK modeling and simulation in drug research and development
Zhuang, X., & Lu, C. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.04.004 · Cited by 410
Descriptors and their selection methods in QSAR analysis: paradigm for drug design
Danishuddin, & Khan, A. U. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.013 · Cited by 388
In silico ADME/T modelling for rational drug design
Wang, Y., Xing, J., Xu, Y., Zhou, N., Peng, J., Xiong, Z., Liu, X., Luo, X., Luo, C., Chen, K., et al. (2015) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583515000190 · Cited by 367
Rostami-Hodjegan, A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.65 · Cited by 331 · cited 1×
“…of in vitro-in vivo extrapolation (IVIVE) in PBPK, many researchers have predicted the disposal of drugs in vivo through in vitro metabolism and transport data, indicating that metabolic enzymes and transporter expression data have become important physiological parameters (Rostami-Hodjegan, 2012).”
BackgroundThe Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery
Lin, J., Sahakian, D., de Morais, S., Xu, J., Polzer, R., & Winter, S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452096 · Cited by 327
Chemical predictive modelling to improve compound quality
Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., & Chen, H. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4128 · Cited by 311
Fan, J., & de Lannoy, I. A. M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.007 · Cited by 309
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR
Sheridan, R. P., Feuston, B. P., Maiorov, V. N., & Kearsley, S. K. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049782w · Cited by 298
In Silico ADMET Prediction: Recent Advances, Current Challenges and Future Trends
Cheng, F., Li, W., Liu, G., & Tang, Y. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990033 · Cited by 295
Whole Body Pharmacokinetic Models
Nestorov, I. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342100-00002 · Cited by 290
Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200542m · Cited by 289
Yang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00030 · Cited by 280
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Cherkasov, A., Li, J., Gramatica, P., Hansen, K., Schroeter, T., Müller, K.-R., et al. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100253r · Cited by 258
vNN Web Server for ADMET Predictions
Schyman, P., Liu, R., Desai, V., & Wallqvist, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00889 · Cited by 254
Xu, Y., Pei, J., & Lai, L. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00244 · Cited by 250
The emerging importance of predictive ADME simulation in drug discovery
Selick, H. E., Beresford, A. P., & Tarbit, M. H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02100-6 · Cited by 233
In silico ADME-Tox modeling: progress and prospects
Alqahtani, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1389897 · Cited by 231
In Silico Approaches for Predicting ADME Properties of Drugs
Yamashita, F., & Hashida, M. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.327 · Cited by 216
Computational toxicology in drug development
Muster, W., Breidenbach, A., Fischer, H., Kirchner, S., Müller, L., & Pähler, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.007 · Cited by 215
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., Thomas, C. D., Hetzel, S. J., Henriquez, K. M., Ribaudo, A. S., et al. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0540-6 · Cited by 188
ADME–Tox in drug discovery: integration of experimental and computational technologies
Yu, H., & Adedoyin, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02828-9 · Cited by 179
Warr, W. A. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9260-9 · Cited by 176
Applying machine learning techniques for ADME-Tox prediction: a review
Maltarollo, V. G., Gertrudes, J. C., Oliveira, P. R., & Honorio, K. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.980814 · Cited by 176
lazar: a modular predictive toxicology framework
Maunz, A., Gütlein, M., Rautenberg, M., Vorgrimmler, D., Gebele, D., & Helma, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00038 · Cited by 174
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Edginton, A. N., Theil, F., Schmitt, W., & Willmann, S. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1143 · Cited by 173
Distributed structure-searchable toxicity (DSSTox) public database network: a proposal
Richard, A. M., & Williams, C. R. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00289-5 · Cited by 168
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Li, M., Zou, P., Tyner, K., & Lee, S. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0010-3 · Cited by 165
Structure‐based Drug Metabolism Predictions for Drug Design
Sun, H., & Scott, D. O. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00899.x · Cited by 162
Wu, Z., Lei, T., Shen, C., Wang, Z., Cao, D., & Hou, T. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00801 · Cited by 158
Physiologically based pharmacokinetics (PBPK)
Espié, P., Tytgat, D., Sargentini-Maier, M.-L., Poggesi, I., & Watelet, J. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891360 · Cited by 157
Computational toxicology—a tool for early safety evaluation
Merlot, C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.010 · Cited by 156
Recent density functional theory model calculations of drug metabolism by cytochrome P450
Li, D., Wang, Y., & Han, K. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.01.016 · Cited by 149
Tian, S., Li, Y., Wang, J., Zhang, J., & Hou, T. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100444g · Cited by 148
Issa, N. T., Wathieu, H., Ojo, A. O., Byers, S. W., & Dakshanamurthy, S. (2017) · Current Drug Metabolism · doi:10.2174/1389200218666170316093301 · Cited by 148
Rowland, M., Balant, L., & Peck, C. C. (2004) · AAPS PharmSci · doi:10.1208/ps060106 · Cited by 137
In silico approaches and tools for the prediction of drug metabolism and fate: A review
Kazmi, S. R., Ren, J., Yu, M., Jung, C., & Na, D. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.01.008 · Cited by 137
Improving Early Drug Discovery through ADME Modelling: An Overview
Wishart, D. S. (2007) · Drugs in R&D · doi:10.2165/00126839-200708060-00003 · Cited by 136
Wang, S., Sun, H., Liu, H., Li, D., Li, Y., & Hou, T. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00471 · Cited by 133
de Graaf, C., Oostenbrink, C., Keizers, P. H. J., van der Wijst, T., Jongejan, A., & Vermeulen, N. P. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508538 · Cited by 131
Khan, M. T. H. (2010) · Current Drug Metabolism · doi:10.2174/138920010791514306 · Cited by 127
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Niederalt, C., Kuepfer, L., Solodenko, J., Eißing, T., Siegmund, H., Block, M. S., Willmann, S., & Lippert, J. (2017) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9559-4 · Cited by 127
Applications of Machine Learning Methods in Drug Toxicity Prediction
Zhang, L., Zhang, H., Ai, H., Hu, H., Li, S., Zhao, J. H., & Liu, H. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180727152557 · Cited by 124
Designing better drugs: predicting cytochrome P450 metabolism
de Groot, M. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.001 · Cited by 122
Schlender, J., Meyer, M. C., Thelen, K., Krauß, M., Willmann, S., Eißing, T., & Jaehde, U. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0422-3 · Cited by 119
Nisha, C. M., Kumar, A., Vimal, A., Bai, B. M., Pal, D., & Kumar, A. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.03.001 · Cited by 117
Challenges and opportunities with modelling and simulation in drug discovery and drug development
Lavé, T., Parrott, N., Grimm, H. P., Fleury, A., & Reddy, M. (2007) · Xenobiotica · doi:10.1080/00498250701534885 · Cited by 115
Simoneau, C., den Eede, L. V., & Valzacchi, S. (2012) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2011.644588 · Cited by 114
Collaborative development of predictive toxicology applications
Hardy, B. J., Douglas, N., Helma, C., Rautenberg, M., Jeliazkova, N., Jeliazkov, V., Nikolova, I., Benigni, R., Tcheremenskaia, O., Krämer, S., et al. (2010) · Journal of Cheminformatics · doi:10.1186/1758-2946-2-7 · Cited by 114
Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools
Tao, L., Zhang, P., Qin, C., Chen, S., Zhang, C., Chen, Z., Zhu, F., Yang, S., Wei, Y. Q., & Chen, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.014 · Cited by 111
Helma, C. (2006) · Molecular Diversity · doi:10.1007/s11030-005-9001-5 · Cited by 110
Kim, S., Heo, S.-H., Lee, D., Hwang, I., Lee, Y., & Cho, H. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.09.017 · Cited by 110
Yadav, S., Pandey, S. K., Singh, V. K., Goel, Y., Kumar, A., & Singh, S. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176403 · Cited by 106
Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
Bouzom, F., Ball, K., Perdaems, N., & Walther, B. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1767 · Cited by 105
Cao, D., Wang, J., Zhou, R., Li, Y., Yu, H., & Hou, T. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300112j · Cited by 105
ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping
Yang, H., Sun, L., Wang, Z., Li, W., Liu, G., & Tang, Y. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00532 · Cited by 102
Jiang, D., Lei, T., Wang, Z., Shen, C., Cao, D., & Hou, T. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00421-y · Cited by 102
SuperToxic: a comprehensive database of toxic compounds
Schmidt, U., Struck, S., Grüning, B. A., Hossbach, J., Jaeger, I. S., Parol, R., Lindequist, U., Teuscher, E., & Preißner, R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn850 · Cited by 100
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women
Dallmann, A., Ince, I., Solodenko, J., Meyer, M. C., Willmann, S., Eißing, T., & Hempel, G. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0538-0 · Cited by 95
ToxRefDB version 2.0: Improved utility for predictive and retrospective toxicology analyses
Watford, S., Pham, L., Wignall, J., Shin, R., Martin, M. T., & Friedman, K. P. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.07.012 · Cited by 92
Alam, S., & Khan, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-41984-7 · Cited by 88
ADME Optimization and Toxicity Assessment in Early- and Late-Phase Drug Discovery
Caldwell, G. W., Yan, Z., Tang, W., et al. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630929 · Cited by 87
Parrott, N. J., Yu, L. J., Takano, R., Nakamura, M., & Morcos, P. N. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9957-3 · Cited by 77
CEBS: a comprehensive annotated database of toxicological data
Lea, I. A., Gong, H., Paleja, A., Rashid, A., & Fostel, J. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1077 · Cited by 76
Zhou, D., Afzelius, L., Grimm, S. W., Andersson, T. B., Zauhar, R. J., & Zamora, I. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008631 · Cited by 75
Why QSAR Fails: An Empirical Evaluation Using Conventional Computational Approach
Huang, J., & Fan, X. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100423u · Cited by 72
Azad, I., Nasibullah, M., Khan, T., Hassan, F., & Akhter, Y. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.02.013 · Cited by 70
Kemp, C. A., Flanagan, J. U., van Eldik, A. J., Maréchal, J., Wolf, C. R., Roberts, G. C. K., Paine, M. J. I., & Sutcliffe, M. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049934e · Cited by 69
Cui, Q., & Karplus, M. (2003) · Advances in protein chemistry · doi:10.1016/s0065-3233(03)66008-0 · Cited by 68
Structural Analysis and Identification of Colloidal Aggregators in Drug Discovery
Yang, Z., Yang, Z., Dong, J. N., Wang, L., Zhang, L., Ding, J., Ding, X., Lü, A., Hou, T., & Cao, D. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00541 · Cited by 68
The physicochemical approach to drug design and discovery (QSAR)
Hansch, C. H. (1981) · Drug Development Research · doi:10.1002/ddr.430010403 · Cited by 66
An ensemble model of QSAR tools for regulatory risk assessment
Pradeep, P., Povinelli, R. J., White, S. M., & Merrill, S. J. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0164-0 · Cited by 66
Buck, S. S. D., & Mackie, C. E. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.6.865 · Cited by 65
A confidence predictor for logD using conformal regression and a support-vector machine
Lapins, M., Arvidsson, S., Lampa, S., Berg, A., Schaal, W., Alvarsson, J., & Spjuth, O. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0271-1 · Cited by 65
Pharmaceutical Perspectives of Nonlinear QSAR Strategies
Michielan, L., & Moro, S. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100072z · Cited by 64
Onghena, M., Hoeck, E. V., Vervliet, P., Scippo, M. L., Simon, C., Loco, J. V., & Covaci, A. (2014) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2014.979372 · Cited by 64
Perdaems, N., Blasco, H., Vinson, C., Chenel, M., Whalley, S., Cazade, F., & Bouzom, F. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318130-000000000-00000 · Cited by 63
Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling
Bouzom, F., & Walther, B. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00648.x · Cited by 63
Gupta, P., Kamath, A. V., Park, S., Chiu, H. H., Lutman, J., Maia, M., Tan, M., Xu, M., Swem, L. R., & Deng, R. (2016) · mAbs · doi:10.1080/19420862.2016.1167294 · Cited by 62
Self-citationFu, L., Liu, L., Yang, Z., Li, P., Ding, J., Yun, Y., Lü, A., Hou, T., & Cao, D. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00718 · Cited by 56
Chen, W., Desai, D., Good, D., Crison, J. R., Timmins, P., Paruchuri, S. R., Wang, J., & Ha, K. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0423-9 · Cited by 54
Shaaban, S., Fasseur, D., Andreoletti, P., Zarrouk, A., Richard, P., Negm, A., Manolikakes, G., Jacob, C., & Cherkaoui‐Malki, M. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.05.019 · Cited by 54
Chedik, L., Mias‐Lucquin, D., Bruyère, A., & Fardel, O. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14070708 · Cited by 51
Roman, M., Roman, D. L., Ostafe, V., Ciorsac, A. A., & Isvoran, A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2353-1 · Cited by 51
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials
Molina, I., Salvador, F., Sánchez‐Montalvá, A., Artaza, M. A., Moreno, R., Perin, L., Esquisabel, A., Pinto, L., & Pedraz, J. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01912-16 · Cited by 49
Prediction of Anti‐Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico
Das, S. K., Laskar, M. A., Sarker, S. D., Choudhury, M. D., Choudhury, P. R., Mitra, A., Jamil, S., Lathiff, S. M. A., Abdullah, S. A., Basar, N., et al. (2017) · Phytochemical Analysis · doi:10.1002/pca.2679 · Cited by 49
Ensemble-based docking: From hit discovery to metabolism and toxicity predictions
Evangelista, W., Weir, R. L., Ellingson, S. R., Harris, J. B., Kapoor, K., Smith, J. C., & Baudry, J. Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.064 · Cited by 48
Pathak, S. M., Schaefer, K. J., Jamei, M., & Turner, D. B. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.034 · Cited by 48
Vaidhyanathan, S., Wang, X., Crison, J. R., Varia, S. A., Gao, J., Saxena, A., & Good, D. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.005 · Cited by 47
Self-citationShang, J., Sun, H., Liu, H., Chen, F., Tian, S., Pan, P., Li, D., De, K., & Hou, T. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0212-4 · Cited by 45
Physiology-based pharmacokinetic modeling: ready to be used
Schmitt, W., & Willmann, S. (2005) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2005.01.001 · Cited by 44
Molecular modeling in the age of clinical genomics, the enterprise of the next generation
Prokop, J. W., Lazar, J., Crapitto, G., Smith, D. C., Worthey, E. A., & Jacob, H. J. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3258-3 · Cited by 44
Reddy, K. K., Singh, S. K., Tripathi, S. K., Selvaraj, C., & Suryanarayanan, V. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.789912 · Cited by 43
Uba, A. İ., & Yelekçi, K. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1384402 · Cited by 43
Pérez‐Nueno, V. I., & Ritchie, D. W. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100492r · Cited by 42
Simulation models for drug disposition and drug interactions
Dickins, M., & Waterbeemd, H. V. D. (2004) · Drug Discovery Today BIOSILICO · doi:10.1016/s1741-8364(04)02388-1 · Cited by 42
Delaney, S. R., Malik, P. R. V., Stefan, C., Edginton, A. N., Colantonio, D., & Ito, S. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0657-2 · Cited by 40
Chow, E. C. Y., Talattof, A., Tsakalozou, E., Fan, J., Zhao, L. Y., & Zhang, X. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9964-4 · Cited by 39
Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents
Waseem, D., Butt, A. F., Haq, I., Bhatti, M. H., & Khan, G. M. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0174-0 · Cited by 39
Physiology-based pharmacokinetic modeling: ready to be used
Schmitt, W., & Willmann, S. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.09.006 · Cited by 39
Onghena, M., Hoeck, E. V., Loco, J. V., Ibáñez, M., Cherta, L., Portolés, T., Pitarch, E., Hernández, F. J., Lemière, F., & Covaci, A. (2015) · Journal of Mass Spectrometry · doi:10.1002/jms.3644 · Cited by 38
Hansmann, S., Darwich, A., Margolskee, A., Aarons, L., & Dressman, J. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12618 · Cited by 38
T’jollyn, H., Vermeulen, A., & Bocxlaer, J. V. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0277-7 · Cited by 38
In silico genotoxicity and carcinogenicity prediction for food-relevant secondary plant metabolites
Glück, J., Buhrke, T., Frenzel, F., Braeuning, A., & Lampen, A. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.04.024 · Cited by 37
David‐Neto, E., Romano, P., Triboni, A. H. K., Ramos‐Delgado, F., Agena, F., Ebner, P. D. A. R., Altona, M., Galante, N. Z., & Lemos, F. B. C. (2016) · Transplantation · doi:10.1097/tp.0000000000001369 · Cited by 35
Khalid, S., Zahid, M., Ali, H., Kim, Y. S., & Khan, S. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0472-6 · Cited by 35
Daga, P. R., Bolger, M. B., Haworth, I. S., Clark, R. D., & Martin, E. J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00972 · Cited by 33
The Ups and Downs of Structure–Activity Landscapes
Guha, R. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_3 · Cited by 33
Kavitha, R., Karunagaran, S., Chandrabose, S. S., Lee, K. W., & Meganathan, C. (2015) · Biosystems · doi:10.1016/j.biosystems.2015.10.005 · Cited by 33
Exploring and Validating Physicochemical Properties of Mangiferin Through GastroPlus ® Software
Khurana, R. K., Kaur, R., Kaur, M., Kaur, R., Kaur, J., Kaur, H., & Singh, B. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0055 · Cited by 31
Moj, D., Britz, H., Burhenne, J., Stewart, C. F., Egerer, G., Haefeli, W. E., & Lehr, T. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3447-x · Cited by 31
Chen, Y., Liu, Z., Fu, T., Li, W., Xu, X., & Sun, H.-P. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.026 · Cited by 30
Doss, C. G. P., Chakraborty, C., Narayan, V., & Kumar, D. T. (2014) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-800168-4.00010-x · Cited by 29
A multiparametric organ toxicity predictor for drug discovery
Patel, C. N., Kumar, S. P., Rawal, R., Patel, D. P., Gonzalez, F. J., & Pandya, H. A. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1681044 · Cited by 29
In silico Prediction of Drug Metabolism by P450
Andrade, C. H., Silva, D. R., & Braga, R. C. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140908102530 · Cited by 28
Jin, Y., Borell, H., Gardin, A., Ufer, M., Huth, F., & Camenisch, G. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2404-2 · Cited by 27
Zhu, L., Zhang, Y., Yang, J.-W., Wang, Y., Zhang, J., Zhao, Y., & Dong, W. (2015) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-015-0271-8 · Cited by 26
Verma, S. K., & Thareja, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175318 · Cited by 26
Yugandhar, P., Kumar, K., Neeraja, P., & Savithramma, N. (2017) · Journal of Intercultural Ethnopharmacology · doi:10.5455/jice.20170709031835 · Cited by 26
Guerra, L. R., de Souza, A. M. T., Côrtes, J. A., Lione, V. D. O. F., Castro, H. C., & Alves, G. G. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.09.030 · Cited by 26
Aswathy, L., Jisha, R. S., Masand, V. H., Gajbhiye, J. M., & Shibi, I. G. (2018) · In Silico Pharmacology · doi:10.1007/s40203-018-0049-1 · Cited by 26
Rawat, R., & Verma, S. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784288 · Cited by 26
Mechanistic insights into the bioactivation of phenacetin to reactive metabolites: A DFT study
Taxak, N., Prasad, K. C., & Bharatam, P. V. (2012) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2012.11.018 · Cited by 25
Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis
de Velde, F., de Winter, B. C. M., Koch, B. C. P., van Gelder, T., & Mouton, J. W. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx376 · Cited by 25
Pharmacokinetics of Penicillin G in Preterm and Term Neonates
Padari, H., Metsvaht, T., Germovsek, E., Barker, C. I. S., Kipper, K., Herodes, K., Standing, J. F., Oselin, K., Tasa, T., Soeorg, H., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02238-17 · Cited by 25
Simhadri, N., Muniappan, M., Kannan, I., & Viswanathan, S. (2017) · Current Medical Mycology · doi:10.29252/cmm.3.4.6 · Cited by 25
Wang, Y., Lin, W., Wu, N., He, X., Wang, J., Feng, Z., & Xie, X. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3790-9 · Cited by 25
Thiel, C., Cordes, H., Conde, I., Castell, J. V., Blank, L. M., & Kuepfer, L. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1723-x · Cited by 24
Yang, H., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00129 · Cited by 24
Mertens, B., Simon, C., Bossuyt, M. V., Onghena, M., Vandermarken, T., Langenhove, K. V., Demaegdt, H., Hoeck, E. V., Loco, J. V., Vandermeiren, K., et al. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.009 · Cited by 23
Shaji, D. (2018) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.07.001 · Cited by 23
Patel, D. B., Daraji, D. G., Patel, K. R., Rajani, D. P., Rajani, S. D., & Patel, H. D. (2020) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3855 · Cited by 23
Tripathi, A. C., Upadhyay, S., Paliwal, S., & Saraf, S. K. (2018) · EXCLI journal · doi:10.17179/excli2017-871 · Cited by 23
Gong, E., Chea, S., Balupuri, A., Kang, N. S., Chin, Y., & Choi, Y. H. (2018) · Molecules · doi:10.3390/molecules23030555 · Cited by 22
Performance of In Silico Models for Mutagenicity Prediction of Food Contact Materials
Bossuyt, M. V., Hoeck, E. V., Raitano, G., Vanhaecke, T., Benfenati, E., Mertens, B., & Rogiers, V. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy057 · Cited by 22
Allosteric inhibition induces an open WPD-loop: a new avenue towards glioblastoma therapy
Agoni, C., Ramharack, P., & Soliman, M. E. S. (2018) · RSC Advances · doi:10.1039/c8ra08427k · Cited by 22
Petrescu, A.-M., Păunescu, V., & Ilia, G. (2019) · Journal of Environmental Science and Health Part B · doi:10.1080/03601234.2019.1574176 · Cited by 22
Watanabe, Y., Fukuyoshi, S., Kato, K., Hiratsuka, M., Yamaotsu, N., Hirono, S., Gouda, H., & Oda, A. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.04.006 · Cited by 21
Absalan, A., Mesbah‐Namin, S. A., Tiraihi, T., & Taheri, T. (2016) · PubMed Central · doi:10.22038/ajp.2016.6785 · Cited by 20
Basheer, L., Schultz, K., & Kerem, Z. (2016) · Scientific Reports · doi:10.1038/srep31557 · Cited by 20
Xeronine structure and function: computational comparative mastery of its mystery
Sanni, D. M., Fatoki, T. H., Kolawole, A. O., & Akinmoladun, A. C. (2017) · In Silico Pharmacology · doi:10.1007/s40203-017-0028-y · Cited by 20
Polepally, A. R., Brundage, R. C., Remmel, R. P., Leppik, I. E., Pennell, P. B., White, J. R., Ramsay, R. E., Kistner, B. M., & Birnbaum, A. K. (2018) · Epilepsia · doi:10.1111/epi.14519 · Cited by 20
Dutour, R., Cortés‐Benítez, F., Roy, J., & Poirier, D. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00265 · Cited by 19
Ye, N., Monk, S. A., Daga, P., Bender, D. M., Rosen, L. B., Mullen, J., Minkwitz, M. C., & Kugler, A. R. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.422 · Cited by 19
Lindstrom, A., Anantpadma, M., Baker, L., Raghavendra, N. M., Davey, R. A., & Davisson, V. J. (2018) · ChemMedChem · doi:10.1002/cmdc.201800587 · Cited by 19
Byun, J. H., Han, D., Cho, H., Yoon, I., & Jung, I. H. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01209-2 · Cited by 19
Pilari, S., Gaub, T., Block, M., & Görlitz, L. (2017) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12205 · Cited by 18
In silico and in vitro inhibition of cytochrome P450 3A by synthetic stilbenoids
Basheer, L., Schultz, K., Guttman, Y., & Kerem, Z. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.06.040 · Cited by 18
Lauro, G., Cantone, V., Potenza, M., Fischer, K., Koeberle, A., Werz, O., Riccio, R., & Bifulco, G. (2018) · MedChemComm · doi:10.1039/c8md00497h · Cited by 18
Song, L., Yu, Z., Xu, Y., Li, X., Liu, X., Liu, D., & Zhou, T. (2020) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2243 · Cited by 18
Computational approaches to the understanding of ADMET properties and problems
Modi, S. P. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02739-9 · Cited by 17
Du, H., Li, J., Cai, Y., Zhang, H., Liu, G., Tang, Y., & Li, W. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00012 · Cited by 16
Wang, L., Hai, Y., An, L., Chen, J., Liang, R., & He, X. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.037 · Cited by 16
Haque, A. K. M. M., Leong, K. H., Lo, Y. L., Awang, K., & Nagoor, N. H. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.05.002 · Cited by 16
Yang, F., Wang, B., Liu, Z., Xia, X., Wang, W., Yin, D., Li, S., & Li, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00683 · Cited by 16
Mohan, A., Kirubakaran, R., Parray, J. A., Sivakumar, R., Murugesh, E., & Govarthanan, M. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.127670 · Cited by 16
Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy
Ramatenki, V., Dumpati, R., Vadija, R., Vellanki, S., Potlapally, S. R., Rondla, R., & Vuruputuri, U. (2017) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-017-2414-7 · Cited by 14
Arora, R., Sharma, M., Monif, T., & Iyer, S. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2015.436 · Cited by 13
In silico and in vitro prediction of the toxicological effects of individual and combined mycotoxins
Taroncher, M., Tolosa, J., Prosperini, A., & Ruiz, M.-J. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.055 · Cited by 13
TN, J., MJ, W., B, K., & RJ, R. (2018) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000365 · Cited by 12
Boetsch, C., Parrott, N. J., Fowler, S. M., Poirier, A., Hainzl, D., Banken, L., Martin‐Facklam, M., & Hofmann, C. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0312-0 · Cited by 12
George, J. K., Singh, S. K., & Verma, P. (2016) · Therapeutic Delivery · doi:10.4155/tde-2015-0004 · Cited by 11
Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives
Poirier, D., Roy, J., Cortés‐Benítez, F., & Dutour, R. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.09.046 · Cited by 11
Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery–a structure-based approach
Ramatenki, V., Dumpati, R., Vadija, R., Vellanki, S., Potlapally, S. R., Rondla, R., & Vuruputuri, U. (2017) · Journal of chemical biology · doi:10.1007/s12154-016-0164-6 · Cited by 11
Saba, N., & Seal, A. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3611-1 · Cited by 11
Zhuang, J., Xing, X., Wang, D., Du, Z., Wang, J., Dong, Y., Yu, W., & Siyal, S. H. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.01.015 · Cited by 11
Sangle, G. V., Patil, M., Deshmukh, N., Shengule, S. A., Kamble, S., Vuppalavanchu, K. K., Kale, S., Baig, M. L. A., Singh, G., Shaikh, J., et al. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2433-5 · Cited by 11
Hu, Y., & Smith, D. E. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084236 · Cited by 11
Systematic characterization of structure–activity relationships and ADMET compliance: a case study
Yongye, A. B., & Medina‐Franco, J. L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.04.002 · Cited by 10
Nandekar, P. P., Khomane, K. S., Chaudhary, V., Rathod, V. P., Borkar, R. M., Bhandi, M. M., Srinivas, R., Sangamwar, A. T., Guchhait, S. K., & Bansal, A. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.061 · Cited by 10
Wang, J., Endsley, A. N., Green, C. E., & Matin, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2508-6 · Cited by 10
Designing the angiogenic inhibitor for brain tumor via disruption of VEGF and IL17A expression
Khan, M. S. S., Majid, A. M. S. A., Iqbal, M. A., Majid, A. S. A., Al‐Mansoub, M. A., & Haque, R. A. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.032 · Cited by 10
Does the Intake of Ethanol Affect Oral Absorption of Poorly Soluble Drugs?
Keemink, J., Sjögren, E., Holm, R., & Bergström, C. A. S. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.12.006 · Cited by 10
Cited by
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337
Singh, S., Kumar, R., Payra, S., & Singh, S. K. (2023) · Cureus · doi:10.7759/cureus.44359 · Cited by 154
Metadata
- Authors
- Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2020-09-11
- Volume
- 8
- Pages
- 726-726
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W3086078626
- Cited by
- 446
- References
- 215
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.